Volume 103, Issue 6, Pages (December 2000)

Slides:



Advertisements
Similar presentations
Darren M Brown, Erkki Ruoslahti  Cancer Cell 
Advertisements

Repression of COUP-TFI Improves Bone Marrow-Derived Mesenchymal Stem Cell Differentiation into Insulin-Producing Cells  Tao Zhang, Xiao-Hang Li, Dian-Bao.
Fig. 7 Localization of the element(s) responsible for the transcriptional suppression by PPAR-γ. A, Rat VSMCs were transfected with either −1969/+104-luc,
Cardiac-Specific Overexpression of HIF-1α Prevents Deterioration of Glycolytic Pathway and Cardiac Remodeling in Streptozotocin-Induced Diabetic Mice 
Mira Park, Ph. D. , Dae-Shik Suh, M. D. , Kangseok Lee, Ph. D
Volume 132, Issue 5, Pages (May 2007)
Volume 11, Issue 6, Pages (June 2003)
Phenotypes of GATA‐1.05/Y germline mutant embryos expressing wild‐type or mutant GATA‐1 transgenes. Phenotypes of GATA‐1.05/Y germline mutant embryos expressing.
Matrix Metalloproteinase 9 Expression is Coordinately Modulated by the KRE-M9 and 12-O-Tetradecanoyl-Phorbol-13-Acetate Responsive Elements  Takashi Kobayashi,
by Milind C. Mahajan, and Sherman M. Weissman
Volume 6, Issue 2, Pages (February 1997)
Volume 138, Issue 2, Pages (February 2010)
Volume 3, Issue 1, Pages (January 1999)
by Shrikanth P. Hegde, JingFeng Zhao, Richard A. Ashmun, and Linda H
Identification and characterization of 2 types of erythroid progenitors that express GATA-1 at distinct levels by Norio Suzuki, Naruyoshi Suwabe, Osamu.
David X Liu, Lloyd A Greene  Neuron 
IFN-γ Upregulates Expression of the Mouse Complement C1rA Gene in Keratinocytes via IFN-Regulatory Factor-1  Sung June Byun, Ik-Soo Jeon, Hyangkyu Lee,
The interferon regulatory factor ICSBP/IRF-8 in combination with PU
Volume 16, Issue 6, Pages (December 2004)
Volume 7, Issue 5, Pages (May 2001)
M. Ushita, T. Saito, T. Ikeda, F. Yano, A. Higashikawa, N. Ogata, U
Sp1 Is Required for Glucose-Induced Transcriptional Regulation of Mouse Vesicular Glutamate Transporter 2 Gene  Tao Li, Liqun Bai, Jing Li, Suzu Igarashi,
A Mechanism for Inhibiting the SUMO Pathway
I-Cheng Ho, Martin R Hodge, John W Rooney, Laurie H Glimcher  Cell 
Qiujie Jiang, Yasushi Matsuzaki, Kehua Li, Jouni Uitto 
Volume 20, Issue 1, Pages (October 2005)
Volume 127, Issue 1, Pages (July 2004)
Yongli Bai, Chun Yang, Kathrin Hu, Chris Elly, Yun-Cai Liu 
Transcriptional Control of the Mouse Col7a1 Gene in Keratinocytes: Basal and Transforming Growth Factor-β Regulated Expression  Michael Naso, Jouni Uitto,
Volume 128, Issue 5, Pages (March 2007)
Volume 1, Issue 7, Pages (June 1998)
Regulation of CSF1 Promoter by the SWI/SNF-like BAF Complex
Yin-Yang 1 Negatively Regulates the Differentiation-Specific Transcription of Mouse Loricrin Gene in Undifferentiated Keratinocytes  Xuezhu Xu, Yasuhiro.
Volume 16, Issue 4, Pages (April 2009)
Volume 7, Issue 5, Pages (May 2001)
Stimulation of Type I Collagen Transcription in Human Skin Fibroblasts by TGF-β: Involvement of Smad 3  Shu-Jen Chen, Weihua Yuan, Yasuji Mori, Anait.
Volume 5, Issue 1, Pages (July 2003)
Darren M Brown, Erkki Ruoslahti  Cancer Cell 
S100A15, an Antimicrobial Protein of the Skin: Regulation by E
Transcription Factor MIZ-1 Is Regulated via Microtubule Association
Volume 62, Issue 3, Pages (September 2002)
Jungmook Lyu, Vicky Yamamoto, Wange Lu  Developmental Cell 
Transcriptional Regulation of ATP2C1 Gene by Sp1 and YY1 and Reduced Function of its Promoter in Hailey–Hailey Disease Keratinocytes  Hiroshi Kawada,
Noritaka Oyama, Keiji Iwatsuki, Yoshimi Homma, Fumio Kaneko 
Volume 55, Issue 6, Pages (June 1999)
Leslie A. Bruggeman, Scott H. Adler, Paul E. Klotman 
Volume 124, Issue 5, Pages (May 2003)
Volume 143, Issue 1, Pages (October 2010)
p53DINP1, a p53-Inducible Gene, Regulates p53-Dependent Apoptosis
Effect of AP1 Transcription Factors on the Regulation of Transcription in Normal Human Epidermal Keratinocytes  Antonello Rossi, Shyh-Ing Jang, Roberta.
Volume 115, Issue 2, Pages (August 1998)
Volume 28, Issue 4, Pages (April 2008)
MyoD Targets TAF3/TRF3 to Activate Myogenin Transcription
JNK Regulates Autocrine Expression of TGF-β1
Volume 61, Issue 6, Pages (June 2002)
Regulation of the Expression of Peptidylarginine Deiminase Type II Gene (PADI2) in Human Keratinocytes Involves Sp1 and Sp3 Transcription Factors  Sijun.
The p73 Gene Is an Anti-Tumoral Target of the RARβ/γ-Selective Retinoid Tazarotene  Marina Papoutsaki, Mauro Lanza, Barbara Marinari, Steven Nisticò, Francesca.
Repression of COUP-TFI Improves Bone Marrow-Derived Mesenchymal Stem Cell Differentiation into Insulin-Producing Cells  Tao Zhang, Xiao-Hang Li, Dian-Bao.
Overexpression of Fetuin-A Counteracts Ectopic Mineralization in a Mouse Model of Pseudoxanthoma Elasticum (Abcc6−/−)  Qiujie Jiang, Florian Dibra, Michael.
Expression of Activated MEK1 in Differentiating Epidermal Cells Is Sufficient to Generate Hyperproliferative and Inflammatory Skin Lesions  Robin M. Hobbs,
TNF Regulates the In Vivo Occupancy of Both Distal and Proximal Regulatory Regions of the MCP-1/JE Gene  Dongsheng Ping, Peter L. Jones, Jeremy M. Boss 
Volume 107, Issue 7, Pages (December 2001)
Volume 31, Issue 6, Pages (December 2009)
Volume 72, Issue 2, Pages (July 2007)
Volume 14, Issue 4, Pages (May 2004)
Mary O'Riordan, Rudolf Grosschedl  Immunity 
Volume 16, Issue 5, Pages (December 2004)
Jörg Hartkamp, Brian Carpenter, Stefan G.E. Roberts  Molecular Cell 
Volume 3, Issue 1, Pages (January 1999)
Targeting expression of a transgene to the airway surface epithelium using a ciliated cell-specific promoter  Lawrence E Ostrowski, James R Hutchins,
Presentation transcript:

Volume 103, Issue 6, Pages 865-876 (December 2000) Positive or Negative MARE-Dependent Transcriptional Regulation Is Determined by the Abundance of Small Maf Proteins  Hozumi Motohashi, Fumiki Katsuoka, Jordan A Shavit, James Douglas Engel, Masayuki Yamamoto  Cell  Volume 103, Issue 6, Pages 865-876 (December 2000) DOI: 10.1016/S0092-8674(00)00190-2

Figure 1 Anemic Founder Embryos Bearing a GATA-1-directed MafK Transgene F0 analysis of fertile oocyte injection of G1-HRD-MafK. (A and B) Representative transgenic embryos at E10.5 (TG+) are depicted alongside transgene-negative littermates (WT). (C–F) Histological examination of E10.5 F0 embryos. An embryo bearing the G1-HRD-MafK transgene (C and E; TG+) and a wild-type littermate (D and F; WT) were sectioned. (C) and (D) are cross sections stained with hematoxylin and eosin. (E) and (F) were immunostained with anti-hemoglobin antibody (light brown) and then counterstained with methyl green. Abbreviations: a, aorta; h, heart; v, cardinal vein. Scale bar corresponds to 210 μm (C and D) or 175 μm (E and F). (G) Gene expression in E9.5 F0 yolk sacs. RNA was extracted from whole yolk sacs, and semiquantitative RT-PCR was performed. Lanes 1 and 2 are samples from pale, small, very anemic transgenic embryos, whereas lane 3 was an only slightly anemic founder. Lanes 4 and 5 are wild-type control littermates. Lane 6 is water. Cell 2000 103, 865-876DOI: (10.1016/S0092-8674(00)00190-2)

Figure 2 The MafK Zipper Mutant L2PM4P Does Not Bind MARE DNA nor Affect Transcription (A) DNA binding properties of MafK and MafK L2PM4P were examined by EGMSA. MafK and MafK L2PM4P were in vitro translated and then incubated with a 32P-labeled oligonucleotide containing the MARE (NF-E2) consensus sequence (lanes 2 and 4). NF-E2 p45 was added to the reaction to examine its ability to heterodimerize (lanes 6 and 8). An arrow and an arrowhead indicate the positions of shifted bands composed of MafK homodimers or of MafK/p45 NF-E2 heterodimers, respectively. The bands were specifically competed by the addition of a 400-fold molar excess of unlabeled oligonucleotide (lanes 3 and 7). Wheat germ extract (WG) without template DNA was a negative control (lane 5). (B) Transfection was performed in NIH3T3 cells. Relative luciferase activity is shown, and luciferase activity without addition of effector plasmids was arbitrarily set at 100%. The amount of transfected effector plasmids, pIM-MafK and pIM-MafK L2PM4P, is shown at the bottom. This represents the average of three independent experiments, and error bars indicate the standard deviation between experiments. (C) Immunoblot analysis of nuclear extracts prepared from transfected NIH3T3 cells. NIH3T3 cells were transfected with pIM-MafK, pIM-MafK L2PM4P, or vector. Ten micrograms of each nuclear extract was applied per lane; MafK was detected by reaction with anti-p18 (MafK) antibody. Molecular size markers are on the right. Cell 2000 103, 865-876DOI: (10.1016/S0092-8674(00)00190-2)

Figure 3 Small Maf Transgenic Mice Display Altered MARE Binding Activity and Inhibited Proplatelet Formation in Megakaryocytes (A) MafK expression levels were analyzed in nuclear extracts recovered from total bone marrow cells of adult transgenic mice by immunoblotting using the anti-p18 (MafK) antibody. Line 28 bears G1-HRD-GFP, while the others coincorporated G1-HRD-MafK into the germ line. (B–E) Proplatelet formation was analyzed in bone marrow megakaryocytes of transgenic mice. Cultured megakaryocytes from TgGFP28 (B and C) and TgMafK548 (D and E) are shown. Acetylcholinesterase activity stained dark brown (B and D). GFP-positive megakaryocytes (C and E) and proplatelet filaments (C) were observed by fluorescence microscopy. (F) MARE binding activity in megakaryocytes isolated from MafK transgenic mice. 1.5 μg of nuclear extract from WT (lanes 1–4), TgMafK686 (lanes 5–8), or TgMafK548 (lanes 9–13) was incubated with a 32P-labeled oligonucleotide containing the NF-E2/MARE consensus sequence. The array of complexes formed (in the absence of antisera) are indicated by an arrow. WG, wheat germ extract. (G) Total small Maf expression levels in adult transgenic bone marrow were determined using anti-small Maf antiserum (Experimental Procedures). All lines shown bear G1-HRD-MafG/GFP transgenes. Cell 2000 103, 865-876DOI: (10.1016/S0092-8674(00)00190-2)

Figure 4 Proplatelet Formation and Thromboxane Synthetase Expression in Megakaryocytes of Mice Expressing Different Levels of Small Maf (A) Small Maf expression levels in compound mutant mice were examined (see Figure 3G). Two representative high level producers (TgMafK686 and TgMafG825) are shown in both wild-type and mafG−/− backgrounds. (B–E) Proplatelet formation was analyzed in megakaryocytes from a wild-type mouse (B), its mafG null littermate (C), a mafG−/− ::TgMafK548 mouse (D), and a mafG−/− ::TgGFP28 mouse (E). Acetylcholinesterase activity stains dark brown (B and C), and GFP-positive megakaryocytes were observed by fluorescence microscopy (D and E). (F) Thromboxane synthetase (TXS) mRNA levels were determined by real-time quantitative RT-PCR (Experimental Procedures). The expression levels were normalized to ribosomal RNA in the same cDNA preparation. TXS mRNA was reduced in mafG null megakaryocytes compared to that in wild-type megakaryocytes (left). TXS mRNA was also reduced in megakaryocytes of two different MafK transgenic lines (548 and 549) (middle). TXS mRNA levels are fully or partially restored in mafG−/− ::TgMafK548 or mafG−/− ::TgMafK549 compound mutant mice (right). Each value represents the average of three different RNA samples, and the error bar indicates the standard deviation. Cell 2000 103, 865-876DOI: (10.1016/S0092-8674(00)00190-2)

Figure 5 In Vivo Titration of Small Maf Activity Is Required for Maximum PPF When small Maf proteins are low, such as in mafG null mutant megakaryocytes, PPF frequency is also low. In small Maf surplus, such as in megakaryocytes from MafK or MafG-overexpressing transgenic mice, PPF is also low. PPF is recovered in megakaryocytes from mafG−/− ::TgMafK/GFP or TgMafG/GFP compound mutant mice according to the expression level of the transgene. Cell 2000 103, 865-876DOI: (10.1016/S0092-8674(00)00190-2)